Apcibiotech.com

Apcibiotech.com has Server used 148.66.138.173 IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2018-04-16 (3 years, 165 days) and hosted in United States, server ping response time 247 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Apcibiotech keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Apc biotechnology services
2 Api biotech
3 Api biotech term
4 Aci biotech import and export co. ltd
5 Apitech
6 Apci technology
7 Apitech corp
8 Apci technology lng
9 Apitechph

Hosting Provider

Website: Apcibiotech.com
Hostname: 148.66.138.173
Country:
Latitude: 37.750999450684
Longitude: -97.821998596191
Area Code: 0
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Revo.com (2 hours ago)

   » Bobbyjonesband.com (1 day ago)

   » 1stchoiceautosllc.com (13 hours ago)

   » Huishoubao.com (1 day ago)

   » M1file.com (1 day ago)

   » Renhomesantalya.com (1 day ago)

   » Napadrivertours.com (23 hours ago)

Results For Websites Listing

Found 44 Websites with content related to this domain, It is result after search with search engine

Apcibiotech – 3rd Party Manufacture In Chandigarh

Apcibiotech.com   DA: 19 PA: 19 MOZ Rank: 38

Welcome to Apci Biotech - Leading Pharma Manufacturer | For Any Enquiry - Contact Us:+91 8580837241,+91 9312005517 , apcibiotech@gmail.com

PCI Biotech

Pcibiotech.no   DA: 17 PA: 17 MOZ Rank: 35

  • Financial calendar for PCI Biotech Holding ASA
  • PCI Biotech first half-year 2021 interim results
  • Aug 31, 2021 <- Older entries
  • Sign up with your email address to receive news and updates

Pharmaceutical Medicine And Nutritional Supplements

Indiamart.com   DA: 17 PA: 13 MOZ Rank: 32

  • Incepted in the year 2018 at Baddi (Himachal Pradesh, India), we “APCI Biotech” are the leading manufacturer of a commendable and premium quality array of Energy Drink Powders, Pharmaceutical Syrups And Suspension, Nutritional Supplements, etc
  • We are a Partnership company and manufacture the high-quality range of products in varied specifications to fulfill …

NEWS — PCI Biotech

Pcibiotech.no   DA: 17 PA: 5 MOZ Rank: 25

  • Ole Morten Christoffersen August 23, 2021
  • PCI Biotech: US patent for the vaccine technology (fimaVACC) in combination with checkpoint inhibitors
  • Ole Morten Christoffersen May 31, 2021
  • PCI Biotech receives Orphan Drug Designation in South Korea for fimaporfin in the treatment of bile duct cancer
  • Ole Morten Christoffersen May 28, 2021.

PCI Biotech: Employee Share Option Scheme IT Business Net

Corporatemedianews.com   DA: 22 PA: 50 MOZ Rank: 76

  • Oslo, 6 September 2021 In accordance with the authorisation granted and the remuneration policy adopted by the Annual General Meeting 28 May 2021, the Board of Directors of PCI Biotech Holding ASA (“PCI Biotech”) has awarded a total of 485,000 share options to key employees
  • Each share option gives the right to

PCI Biotech: Employee Share Option Scheme – Corona Virus

Vaccine.tv   DA: 14 PA: 42 MOZ Rank: 61

PCI Biotech: Employee share option scheme Related Post Gritstone Announces Dosing of First Solid Tumor Patient with Optimized SLATE “Off-the-Shelf” Mutant KRAS-directed Neoantigen Immunotherapy in

Pharmaceutical Calibrations & Instrumentation, Commissioning

Pci-llc.com   DA: 15 PA: 15 MOZ Rank: 36

  • PCI proudly serves Pharmaceutical, Biotechnology, Medical Device, and Clinical Research industries nationwide with Calibrations, Commissioning and Consulting Solutions
  • FDA, EPA and ISO/IEC 17025:2017-compliant! Meet us here.

Welcome. We Are PCI Pharma Services. Let's Talk Future

Pci.com   DA: 7 PA: 7 MOZ Rank: 21

  • Pharmaceutical Packaging Design and Development Services
  • Standard & Specialty Dosage Forms
  • Pharmaceutical Product Launch and Speed-to-Market
  • Patient Compliance and Adherence
  • Commercial Packaging of Biologically-Derived Products
  • Packaging and Analytical Laboratory Services

Biotech, Pharmaceutical And Clinical Research News BioSpace

Biospace.com   DA: 16 PA: 6 MOZ Rank: 30

  • IONOVA Life Science Announces New Financing Round of USD $100 Million
  • On August 27, 2021, Shenzhen IONOVA Life Science Co., Ltd
  • ("IONOVA" or "the company"), a clinical-stage biotechnology company located in the Guangdong-Hong Kong-Macao Greater Bay Area of China, announced completion of a new financing round of USD …

The Bacon Portfolio – Alpha, Biotech, Crypto

Thebaconportfolio.wordpress.com   DA: 31 PA: 31 MOZ Rank: 71

Savepig Invest Read my portfolio updates Latest from the Blog bitcoin:bc1q3zxys2zpqftcq8fpenpf4hs4g728cgcle46r70

GI Cancer Conference

Cedars.cloud-cme.com   DA: 20 PA: 9 MOZ Rank: 39

  • Cedars-Sinai, GI Cancer Conference, 2/10/2018 7:45:00 AM - 2/10/2018 12:50:00 PM, The second annual Cedars-Sinai Gastrointestinal Cancer Conference will provide concise and comprehensive updates on the most recent results and advances in targeted therapies for gastrointestinal cancers
  • A stellar faculty has been assembled to share developments in …

PCI Biotech: Invitation To First Half-year 2021 Result

Globenewswire.com   DA: 21 PA: 50 MOZ Rank: 82

PCI Biotech is a biopharmaceutical late stage clinical development company focusing on development and commercialisation of novel therapies for the treatment of cancer through its innovative

Stock News PCI BIOTECH Stock Price Today Analyst

Markets.businessinsider.com   DA: 27 PA: 25 MOZ Rank: 64

  • PCI Biotech Holding ASA engages in the research and development of biopharmaceutical products for cancer treatment
  • Its photochemical internalization technology therapy enhances the effect of

PCIB: PCI Biotech Holding ASA Stock Price Quote

Bloomberg.com   DA: 17 PA: 14 MOZ Rank: 44

  • PCI Biotech Holding ASA: PCI Biotech: Employee share option scheme

PCI BIOTECH AKTIE News Aktienkurs Dividende Chart

Finanzen.net   DA: 16 PA: 25 MOZ Rank: 55

  • PCI BIOTECH AKTIE und aktueller Aktienkurs
  • Nachrichten zur Aktie PCI Biotech Holding ASA | A0Q2FS | NO0010405640

PCI BIOTECH HLDG (PCIB.OL) Stock Price, News, Quote

Finance.yahoo.com   DA: 17 PA: 15 MOZ Rank: 47

  • PCI Biotech: Invitation to first half-year 2021 result presentation
  • Oslo, Norway, 23 August 2021 - PCI Biotech’s (OSE: PCIB) first half-year 2021 interim report will be released on 31 August

PCI Biotech

Zoominfo.com   DA: 16 PA: 31 MOZ Rank: 63

  • PCI Biotech: US patent for the vaccine technology (fimaVacc) in combination with checkpoint inhibitors Oslo (Norway), 31 May 2021 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces that the U.S
  • Patent and Trademark Office (USPTO) has informed the company that a new US patent will be granted early June 2021.

Fimaporfin/gemcitabine

Adisinsight.springer.com   DA: 24 PA: 16 MOZ Rank: 57

  • A combination of fimaporfin and gemcitabine is being developed by PCI Biotech, for the treatment of cholangiocarcinoma
  • Fimaporfin (TPCS 2a, Amphinex®), an

PCI Biotech: European Patent For Treatment Of Bile Duct

Globenewswire.com   DA: 21 PA: 50 MOZ Rank: 89

PCI Biotech is a biopharmaceutical late stage clinical development company focusing on development and commercialisation of novel therapies for the treatment of cancer through its innovative

PCI Biotech Holding ASA LinkedIn

Linkedin.com   DA: 16 PA: 32 MOZ Rank: 67

PCI Biotech is a biopharmaceutical late stage clinical development company focusing on development and commercialisation of novel therapies …

PCIB PCI Biotech Holding ASA Stock Price & News

Wsj.com   DA: 11 PA: 27 MOZ Rank: 58

  • News PCI Biotech Holding ASAPCIB
  • No news for PCIB in the past two years
  • The Price to Earnings (P/E) ratio, a key valuation measure, is calculated …

PCI Biotech AS

Bionity.com   DA: 15 PA: 39 MOZ Rank: 75

  • PCI Biotech is a biopharmaceutical company focusing on development and commercialisation of novel therapies for the treatment of cancer through its innovative photochemical internalisation (PCI) technology platform
  • PCI is applied to three distinct anticancer paradigms: fimaCHEM (enhancement of chemotherapeutics for localised treatment of

Lytix Biopharma LinkedIn

Linkedin.com   DA: 16 PA: 24 MOZ Rank: 62

  • Lytix Biopharma | 1,217 followers on LinkedIn
  • A clinical-stage biotech company developing proprietary oncolytic peptides as a novel immune therapy to fight cancer

PCI Biotech VentureRadar

Ventureradar.com   DA: 20 PA: 50 MOZ Rank: 93

  • PCI Biotech is a biopharmaceutical company focusing on development and commercialisation of novel therapies for the treatment of cancer through its innovative photochemical internalisation (PCI) technology platform
  • VentureRadar Research / Company Website

Fimaporfin Delivered Cancer Vaccine

Adisinsight.springer.com   DA: 24 PA: 16 MOZ Rank: 64

  • 31 May 2021 PCI Biotech has patents pending for fimaVacc in combination with checkpoint inhibitors in Europe and Asia
  • 28 Nov 2020 No recent reports of development identified for phase-I development in Cancer (In volunteers) in United Kingdom (Intradermal) 27 Nov 2020 Fimaporfin delivered cancer vaccine - PCI Biotech is available for licensing

PCI Biotech: US Patent Granted For The Vaccine Technology

Finance.yahoo.com   DA: 17 PA: 50 MOZ Rank: 92

  • PCI Biotech (PCIB.OL), a cancer focused biopharmaceutical company, today announces that the U.S
  • Patent and Trademark Office (USPTO) has granted the company a US patent covering the use of

PCI Biotech Holding ASA Stock Price (PCIB)

Investing.com   DA: 17 PA: 29 MOZ Rank: 72

  • PCI Biotech Holding ASA is a Norway-based company engaged in the biotechnology sector
  • Its activities are focused on the commercialization of a patented photochemical drug delivery technology for

PCI Biotech Holding ASA: PCI Biotech: Preclinical Research

Bloomberg.com   DA: 17 PA: 50 MOZ Rank: 94

PCI Biotech disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or …

PCI Biotech : Q2 2021 MarketScreener

Marketscreener.com   DA: 22 PA: 50 MOZ Rank: 100

  • PCI Biotech Holding ASA, Ullernchausséen 64, 0379 Oslo, Norway, Company no: NO 991036393 VAT Phone: + 47 67 11 54 00, www.pcibiotech.com
  • LEVERAGING THE PCI TECHNOLOGY IN THREE DISTINCT AREAS
  • PCI Biotech is an oncology-focused …

PCIB Stock Price And Chart — OSL:PCIB — TradingView

Tradingview.com   DA: 19 PA: 18 MOZ Rank: 66

  • PCI Biotech: US patent granted for the vaccine technology (fimaVACC) in combination with cytokines Oslo (Norway), 21 January 2020 – PCI Biotech OSL:PCIB , a cancer focused biopharmaceutical company, today announces that the U.S
  • Patent and Trademark Office (USPTO) has granted the company a US patent covering the use of fimaVacc in combination …

Working At PCI Biotech Glassdoor

Glassdoor.com   DA: 17 PA: 50 MOZ Rank: 97

  • See what employees say it's like to work at PCI Biotech
  • Salaries, reviews, and more - all posted by employees working at PCI Biotech.

PCI Biotech

Youtube.com   DA: 15 PA: 6 MOZ Rank: 52

CEO in PCI Biotech Per Walday is interviewed by Arctic Equity Analyst Pål Falck.Important takeaways is that Asia now will be included in the RELEASE study, t

Jobs With PCI Biotech

Biospace.com   DA: 16 PA: 29 MOZ Rank: 77

  • PCI Biotech, a cancer focused biopharmaceutical company announces its third quarter 2019 result
  • PCI Biotech: Extension of Preclinical Research Collaboration Agreement With a Top-10 Large Pharma Company
  • The extended evaluation period spans over 6 months, until the end of June 2018, and may be further extended.

Anders Høgset

No.linkedin.com   DA: 15 PA: 31 MOZ Rank: 79

  • Oslo, Oslo, Norge205 forbindelser
  • Bli med for å knytte kontakt
  • University of Oslo (UiO) Rapporter denne profilen.

Maria Norling

Se.linkedin.com   DA: 15 PA: 26 MOZ Rank: 75

  • PCI Biotech jul 2021 –nu 2 månader
  • Director Clinical Operations OxThera maj 2018 – jul 2021 3 år 3 månader

PCI Biotech: Employee Share Option Scheme

Bollyinside.com   DA: 19 PA: 46 MOZ Rank: 100

Each share alternative gives the correct to subscribe for or get 1 share for each possibility (immediately after PCI Biotech’s choice), at a strike selling price of NOK 19.41, equal to the volume weighted ordinary share price tag (VWAP) for …

Penn Pharma, A PCI Company LinkedIn

Uk.linkedin.com   DA: 15 PA: 42 MOZ Rank: 93

  • Penn Pharma, a PCI company | 4,915 followers on LinkedIn
  • Penn Pharma, a PCI company, has over 35 years of experience in providing integrated drug development, clinical trial supply, manufacturing and packaging services to the international healthcare industry
  • With a full range of contract services available Penn is able to take compounds from the earliest stages of …

PCI Biotech

Ml-eu.globenewswire.com   DA: 23 PA: 50 MOZ Rank: 13

PCI BIOTECH –ENABLING INTRACELLULAR DELIVERY 3 A biotech company with an oncology focused pipeline Photochemical internalisation (PCI) is a platform technology with three programmes targeting an attractive and growing oncology market

PCIB.NO PCI Biotech Holding ASA Financial Statements

Wsj.com   DA: 11 PA: 43 MOZ Rank: 92

  • PCI Biotech Holding ASA balance sheet, income statement, cash flow, earnings & estimates, ratio and margins
  • View PCIB.NO financial statements in full.

Photocure ASA

News.cision.com   DA: 15 PA: 50 MOZ Rank: 11

  • PCI Biotech is a subsidiary of Photocure, a listed pharmaceutical company
  • PCI Biotech has a unique method for delivery of therapeutic molecules directly into the cells
  • The technology called photochemical internalisation (PCI) can be used to improve existing and novel cytotoxic drugs, in addition to development of new and innovative treatment

PCI Biotech

Ml-eu.globenewswire.com   DA: 23 PA: 50 MOZ Rank: 10

  • PCI BIOTECH This presentation will also be presented through a teleconference, mainly facilitated for investors intending to ask questions verbally during the Q&A session
  • If you plan to use this facility, please join the event 5-10 minutes prior to the scheduled start time.

Amir Snapir

Fi.linkedin.com   DA: 15 PA: 14 MOZ Rank: 70

  • Amir Snapir | Turku, West and Inner Finland, Finland | Chief Medical Officer at PCI Biotech Holding ASA | Global clinical development physician with extensive successful pharmaceutical industry experience in development leadership positions from early development to phase 3 - mostly in oncology therapy area
  • | 291 connections | See Amir's complete profile on Linkedin …

Recently Analyzed Sites

Revo.com (2 hours ago)

Bobbyjonesband.com (1 day ago)

1stchoiceautosllc.com (13 hours ago)

Huishoubao.com (1 day ago)

M1file.com (1 day ago)

Napadrivertours.com (23 hours ago)

Trekksoft.com (1 day ago)

Tibbo.com (23 hours ago)

Artopex.com (32 seconds ago)

Tailspinbandsc.com (2 day ago)

Dungscanada.com (7 day ago)

Jfsorange.org (2 day ago)

Marloweslu.com (23 hours ago)